The role of mucus on drug transport and its potential to affect therapeutic outcomes

X Murgia, B Loretz, O Hartwig, M Hittinger… - Advanced drug delivery …, 2018 - Elsevier
A layer of mucus covers the surface of all wet epithelia throughout the human body. Mucus is
a hydrogel mainly composed of water, mucins (glycoproteins), DNA, proteins, lipids, and cell …

Polymeric vehicles for nucleic acid delivery

AS Piotrowski-Daspit, AC Kauffman… - Advanced drug delivery …, 2020 - Elsevier
Polymeric vehicles are versatile tools for therapeutic gene delivery. Many polymers—when
assembled with nucleic acids into vehicles—can protect the cargo from degradation and …

Biotechnologically produced chitosans with nonrandom acetylation patterns differ from conventional chitosans in properties and activities

S Sreekumar, J Wattjes, A Niehues, T Mengoni… - Nature …, 2022 - nature.com
Chitosans are versatile biopolymers with multiple biological activities and potential
applications. They are linear copolymers of glucosamine and N-acetylglucosamine defined …

Coacervates: Recent developments as nanostructure delivery platforms for therapeutic biomolecules

E Ban, A Kim - International Journal of Pharmaceutics, 2022 - Elsevier
Coacervation is a liquid–liquid phase separation that can occur in solutions of
macromolecules through self-assembly or electrostatic interactions. Recently, coacervates …

A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411

Z Khademi, M Ramezani, M Alibolandi, MR Zirak… - Carbohydrate …, 2022 - Elsevier
A facile method was designed that can specifically deliver CRISPR/Cas9 into target cells
nuclei and reduce the off-target effects. A multifunctional delivery vector for FOXM1 knockout …

Amphiphilic quaternized chitosan: Synthesis, characterization, and anti-cariogenic biofilm property

T Phuangkaew, N Booranabunyat… - Carbohydrate …, 2022 - Elsevier
Hydrophobized chitosan derivatives, hexyl chitosan (HCS), dodecyl chitosan (DCS), and
phthaloyl chitosan (PhCS) of approximately 30 and 50% degree of substitution (% DS) …

Chitosan in non-viral gene delivery: Role of structure, characterization methods, and insights in cancer and rare diseases therapies

B Santos-Carballal, E Fernández Fernández… - Polymers, 2018 - mdpi.com
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of
clinical trials of gene therapy nanomedicines. Even when non-viral nanovectors pose less …

Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases

N Gulati, K Dua, H Dureja - International journal of biological …, 2021 - Elsevier
Chitosan-loaded nanomedicines provide a greater opportunity for the treatment of
respiratory diseases. Natural biopolymer chitosan and its derivatives have a large number of …

RNA delivery biomaterials for the treatment of genetic and rare diseases

W Zhao, X Hou, OG Vick, Y Dong - Biomaterials, 2019 - Elsevier
Genetic and rare diseases (GARDs) affect more than 350 million patients worldwide and
remain a significant challenge in the clinic. Hence, continuous efforts have been made to …

PEGylated chitosan for nonviral aerosol and mucosal delivery of the CRISPR/Cas9 system in vitro

H Zhang, TF Bahamondez-Canas, Y Zhang… - Molecular …, 2018 - ACS Publications
Chitosan has been widely employed to deliver nucleic acids such as siRNA and plasmids.
However, chitosan-mediated delivery of a gene-editing system has not been reported yet. In …